Table 2.
Study | Group | Subjects [n] |
Sex [n male; female] |
Age (y) [M; SD] |
LVEF [M; SD] |
VO2 [M; SD] |
---|---|---|---|---|---|---|
Avila et al., 2018 [19] | CTR | 30 | 26; 4 | 58.6; 13 | - | 26.7; 6.55 |
CI | 30 | 27; 3 | 61.9; 7.3 | - | 25.4; 7.32 | |
Avila et al., 2020 [20] | CTR | 26 | 23; 3 | 62.2; 7.1 | - | 26.7; 6.55 |
CI | 29 | 23; 3 | 62.0; 7.4 | - | 25.4; 7.3 | |
Batalik et al., 2021 [21] | CRh | 23 | 19; 4 | 56.1; 6.8 | 59.9; 5.9 | 23.7; 4.0 |
CI | 25 | 22; 3 | 57.2; 7.5 | 58.1; 5.8 | 23.1; 3.0 | |
Batalik et al., 2021a [22] | CRh | 28 | 17; 11 | 56.1; 6.8 | 60.1; 5.8 | 23.7; 4.0 |
CI | 28 | 19; 9 | 57.1; 7.9 | 58.9; 5.5 | 23.0; 3.0 | |
Batalik et al., 2020 [7] | CRh | 25 | 20; 5 | 56.5; 6.9 | 60.2; 5.6 | 23.7; 4.1 |
CI | 26 | 22; 4 | 57.7; 7.6 | 59.2; 5.7 | 23.4; 3.3 | |
Bravo-Escobar et al., 2021 [23] | CRh | 33 | 31; 2 | 56.18; 8.71 | 40–55% | - |
CI | 38 | 35; 3 | 55.32; 7.97 | 40–55% | - | |
Bravo-Escobar et al., 2017 [24] | CRh | 13 | 14; 0 | 56.50; 6.01 | 51.00; 7.9 | - |
CI | 14 | 14; 0 | 55.64; 11.3 | 52.33; 3.51 | - | |
Dale et al., 2015 [25] | CRh | 61 | 48; 13 | 59.0; 10.5 | - | - |
CI | 62 | 52; 10 | 59.9; 11.8 | - | - | |
De Lima et al., 2022 [26] | CRh | 23 | 19; 4 | 58.13; 8.94 | - | - |
CI | 26 | 23; 3 | 54.81; 11.4 | - | - | |
Dorje et al., 2019 [27] | CTR | 156 | 128; 28 | 59.1; 9.4 | 62.9; 6.4 | - |
CI | 156 | 126; 30 | 61.9; 8.7 | 63.2; 6.9 | - | |
Fang et al., 2019 [28] | CTR | 33 | 21; 12 | 60.24; 9.3 | 62.97; 6.8 | - |
CI | 34 | 21; 13 | 61.41; 10.1 | 62.15; 1.16 | - | |
Ghorbani et al., 2021 [29] | CTR | 37 | 24; 13 | - | - | - |
CI | 37 | 19; 18 | - | - | - | |
He et al., 2020 [30] | CRh | 37 | 24; 13 | - | - | - |
CI | 37 | 19; 18 | - | - | - | |
Hong et al., 2020 [31] | CTR | 30 | 23; 7 | 61–70 (53.4%) | - | - |
CI | 30 | 20; 10 | 41–60 (53.4%) | - | - | |
Kraal et al., 2017 [32] | CRh | 45 | 40; 5 | 60.5; 8.8 | - | 24.4; 6.7 |
CI | 45 | 40; 5 | 57.7; 8.7 | - | 24.0; 5.6 | |
Kraal et al., 2014 [33] | CRh | 25 | 22; 3 | 60.6; 7.5 | - | 22.8; 4.2 |
CI | 25 | 21; 4 | 56.1; 8.7 | - | 23.7; 6.4 | |
Lee et al., 2013 [34] | CTR | 26 | 22; 4 | 54.3; 8.9 | 55; 10 | - |
CI | 29 | 22; 7 | 57.8; 7.5 | 50; 10 | - | |
Lee et al., 2013a [35] | CRh | 25 | 18; 7 | 55.56; 9.23 | 52.48; 9.40 | - |
CI | 25 | 19; 6 | 57.88; 7.90 | 62.04; 9.42 | - | |
Maddison et al., 2015 [36] | CTR | 85 | 69; 16 | 61.4; 8.9 | - | 26.8; 6.4 |
CI | 86 | 70; 16 | 59.0; 9.5 | - | 27.1; 6.5 | |
Maddison et al., 2018 [37] | CTR | 82 | 69; 13 | 61.0; 13.2 | - | 27.22; 7.91 |
CI | 80 | 70; 10 | 61.5; 12.2 | - | 27.70; 6.77 | |
Reid et al., 2011 [38] | CTR | 115 | 95; 20 | 56.7; 9.0 | - | - |
CI | 108 | 93; 15 | 56.0; 9.0 | - | - | |
Shi et al., 2022 [39] | CRh | 25 | 21; 4 | 49.80; 7.74 | - | - |
CI | 26 | 19; 7 | 51.38; 7.54 | - | - | |
Skobel et al., 2017 [40] | CRh | 55 | 50; 5 | 60 (50.5%) | 56 (50.65%) | 21.5 (17.2; 24.8) |
CI | 63 | 55; 8 | 58 (52.67%) | 61 (57.70%) | 20 (17.23%) | |
Snoek et al., 2021 [41] | CTR | 89 | 20 | 72.4; 5.4 | - | 18.9; 5.4 |
CI | 90 | 14 | 73.6; 5.5 | - | 20.3; 5.7 | |
Snoek et al., 2021a [42] | CTR | 61 | 50; 11 | 60.0; 8.4 | - | 22.8; 6.0 |
CI | 61 | 50; 11 | 59.0; 10.7 | - | 22.1; 4.8 | |
Song et al., 2020 [43] | CTR | 48 | 43; 5 | 54.17; 8.76 | 63.98; 10.7 | 20.40; 4.57 |
CI | 48 | 40; 8 | 54.83; 9.13 | 66.25; 9.06 | 18.83; 3.98 | |
Su and Yu, 2021 [44] | CTR | 73 | 62; 11 | 55.53; 7.30 | - | - |
CI | 73 | 60; 13 | 56.03; 7.02 | - | - | |
Vieira et al., 2018 [45] | CRh | 11 | - | 55; 9.0 | - | - |
CI | 11 | - | 59; 11.3 | - | - |
Legend: CI = Conventional Intervention; CRh = Cardiac Rehabilitation hybrid; CTR = Cardiac Telerehabilitation; LVEF = Left Ventricular Ejection Fraction. M = mean; SD = Standard Deviation; VO2 = max Oxygen Consumption; y = years.